Screener
PTC Therapeutics PTCT Operating Income
Operating Income at other companies
Other financials
Where this comes from
Reported directly by PTC Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.
The source filing: PTC Therapeutics’s 10-Q, filed May 7, 2026.
- Filed
- May 7, 2026, 4:32 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001070081-26-000012
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Change in the fair value of contingent consideration | — | (800) |
| Tangible asset impairment and losses on transactions, net | 927 | 77 |
| Total operating expenses | 227,592 | 205,871 |
| Income from operations | 44,959 | 970,225 |
| Interest expense, net | (49,030) | (34,092) |
| Other income (expense), net | 1,609 | (6,305) |
| (Loss) income before income tax expense | (2,462) | 929,828 |
| Income tax expense | (347) | (63,266) |
Item 1. Financial Statements (unaudited)
FAQ
- What is PTC Therapeutics's operating income?
- PTC Therapeutics (PTCT) reported operating income of $44.96M in Q1 2026.
- How has PTC Therapeutics's operating income changed year-over-year?
- PTC Therapeutics's operating income decreased by 95.4% year-over-year, from $970.23M to $44.96M.
- What is the long-term trend for PTC Therapeutics's operating income?
- Over 4 years (2021 to 2025), PTC Therapeutics's operating income has grown at a 25.8% compound annual growth rate (CAGR), from -$374.45M to $938.28M.
- What does operating income mean?
- Gross profit minus all operating expenses (SG&A, R&D, D&A). Measures the profit from core business operations before interest, taxes, and non-operating items.
Ask your AI about PTC Therapeutics's operating income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude